Lipid profiles of children and adolescents with inflammatory response in a paediatric emergency department

References

• Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277–83.
   PubMed Web of Science ®Google Scholar
• Morrison JA, Glueck CJ, Wang P. Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study. Metab-Clin Exp. 2012;61:531–41.
   PubMed Web of Science ®Google Scholar
• Magnussen CG, Koskinen J, Juonala M, Chen W, Srinivasan SR, Sabin MA, et al. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk the Bogalusa heart and cardiovascular risk in young Finns studies. J Am Coll Cardiol. 2012;60:1631–9.
   PubMed Web of Science ®Google Scholar
• Juonala M, Jarvisalo MJ, Maki-Torkko N, Kahonen M, Viikari JSA, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the cardiovascular risk in young Finns Study. Circulation. 2005;112:1486–93.
   PubMed Web of Science ®Google Scholar
• Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem. 1986;32:142–5.
   PubMed Web of Science ®Google Scholar
• Chenaud C, Merlani PG, Roux-Lombard P, Burger D, Harbarth S, Luyasu S, et al. Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med. 2004;32:632–7.
   PubMed Web of Science ®Google Scholar
• Gidding SS, Stone NJ, Bookstein LC, Laskarzewski PM. Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr. 1998;133:242–6.
   PubMed Web of Science ®Google Scholar
• Aburawi EH, Grubb A, Raitakari OT, Viikari J, Pesonen EJ. Lowered levels of serum albumin and HDL-cholesterol in children with a recent mild infection. Ann Med. 2006;38:154–60.
   PubMed Web of Science ®Google Scholar
• Soran H, Hama S, Yadav R, Durrington PN. HDL functionality. Curr Opin Lipidol. 2012;23:353–66.
   PubMed Web of Science ®Google Scholar
• Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med. 2007;33:13–24.
   PubMed Web of Science ®Google Scholar
• Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, et al. Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care. 2010;25:361.e7–12.
   Google Scholar
• Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents [on-line]. National Heart, Lung, and Blood Institute; 2012 Oct. Available from: http://www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm. [Accessed on 19 Jun 2014].
   Google Scholar
• Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2013;101:1–20.
   Web of Science ®Google Scholar
• WHO child growth Standards [on-line]. Available from: http://www.who.int/childgrowth/standards/bmi_for_age/en/e http://www.who.int/growthref/who2007_bmi_for_age/en/ [Accessed on 22 April 2014].
   Google Scholar
• May AL, Kuklina EV, Yoon PW. Prevalence of abnormal lipid levels among Youths-United States, 1999–2006 (Reprinted from MMWR, vol 59, pg 29–33, 2010). JAMA. 2010;303:930–3.
   Web of Science ®Google Scholar
• Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden CL. Trends in serum lipids among US youths aged 6 to 19 years, 1988–2010. JAMA. 2012;308:591–600.
   PubMed Web of Science ®Google Scholar
• Moura EC, de Castro CM, Mellin AS, de Figueiredo DB. Lipid profile among school children in Campinas, Brazil. Rev Saude Publica. 2000;34:499–505.
   PubMed Web of Science ®Google Scholar
• Giuliano IC, Coutinho MS, Freitas SF, Pires MM, Zunino JN, Ribeiro RQ. Serum lipids in school kids and adolescents from Florianópolis, SC, Brazil –Healthy Floripa 2040 study. Arq Bras Cardiol. 2005;85:85–91.
   PubMedGoogle Scholar
• Alcântara Neto OD, Silva Rde C, Assis AM, pinto Ede J. Factors associated with dyslipidemia in children and adolescents enrolled in public schools of Salvador, Bahia. Rev Bras Epidemiol. 2012;15:335–45.
   PubMedGoogle Scholar
• Cappi SB, Noritomi DT, Velasco IT, Curi R, Loureiro TCA, Soriano FG. Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis. Intensive Care Med. 2012;38:634–41.
   PubMed Web of Science ®Google Scholar
• van Leeuwen HJ, Heezius E, van Strijp JAG, van Kessel KPM, Dallinga GM, Verhoef J. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31:1359–66.
   PubMed Web of Science ®Google Scholar
• Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KFM, et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med. 2005;33:1610–15.
   PubMed Web of Science ®Google Scholar
• Grion CMC, Cardoso LTQ, Perazolo TF, Garcia AS, Barbosa DS, Morimoto HK, et al. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Eur J Clin Invest. 2010;40:330–8.
   PubMed Web of Science ®Google Scholar
• Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33:1688–93.
   PubMed Web of Science ®Google Scholar
• Lekkou A, Mouzaki A, Siagris D, Ravani I, Gogos CA. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J Crit Care. 2014;29:723–7.
   PubMed Web of Science ®Google Scholar
• Tall AR. PLASMA high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379–84.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, et al. Cholesterol Efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012;125:1905–19.
   PubMed Web of Science ®Google Scholar
• Liuba P, Persson J, Luoma J, Yla-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J. 2003;24:517–23.
   Web of Science ®Google Scholar
• Marsche G, Saemann MD, Heinemann A, Holzer M. Inflammation alters HDL composition and function: implications for HDL raising therapies. Pharmacol Ther. 2013;137:342–51.
   Google Scholar
• Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, Liang XC, et al. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res. 2003;44:1489–98.
   PubMed Web of Science ®Google Scholar
• Birjmohun RS, van Leuven SI, Levels JHM, van 't Veer C, Kuivenhoven JA, Meijers JCM, et al. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol. 2007;27:1153–8.
   PubMed Web of Science ®Google Scholar
• Imai T, Fugita T, Yamazaki Y. Beneficial effects of apolipoprotein A-I on endotoxemia. Surg Today. 2003;33:684–7.
   PubMed Web of Science ®Google Scholar
• Jiao Y-I, Wu M-P. Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid. Cytokine. 2008;43:83–7.
   PubMed Web of Science ®Google Scholar
• Guo L, Ai J, Zheng Z, Howatt DA, Daugherty A, Huang B, et al. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J Biol Chem. 2013;288:17947–53.
   PubMed Web of Science ®Google Scholar